Anti-HBe

Anti-HBe testing is essential for understanding and managing hepatitis B. At IntroLab in Belgrade, we utilize cutting-edge technology to ensure accurate results. Our primary goal is to provide patients with reliable and timely information about their Anti-HBe status, offering a solid foundation for making informed treatment decisions.

What are HBe antibodies?

HBe antibodies, correctly referred to as anti-HBe or HBeAb, play a crucial role in the diagnosis and monitoring of hepatitis B. In the context of hepatitis B, HBeAg indicates active viral replication and a high potential for transmission. When HBeAg is present, it usually signals high infection activity. In contrast, the development of anti-HBe suggests a reduction in viral activity. The appearance of these antibodies and the loss of HBeAg typically indicate that the acute phase of hepatitis B infection is diminishing, and the individual is entering a chronic phase with reduced viral activity. Interpreting these results requires the expertise of a healthcare professional, such as an infectious disease specialist or hepatologist, who will take into account all relevant lab and clinical information.

When is the anti-HBe test performed?

The anti-HBe test, which detects antibodies against the hepatitis B e-antigen, is conducted in various situations. Primarily, this test is recommended when there is a suspicion of hepatitis B virus infection or to monitor the activity of a known infection. Additionally, the anti-HBe test is essential for assessing the effectiveness of treatment in patients with chronic hepatitis B. It is also frequently used for individuals at potential risk of infection, such as healthcare workers or those who have had contact with infected individuals, as part of preventive screening.

What is Hepatitis B?

Hepatitis B is a liver infection caused by the hepatitis B virus.

• Acute hepatitis B is typically characterized by more severe symptoms and can result in serious complications, such as liver failure. However, most adults recover fully from the infection and develop lifelong immunity.
• Chronic hepatitis B can range from mild to severe, potentially leading to long-term liver damage, including cirrhosis and liver cancer.

Hepatitis B is spread through contact with infected blood and other bodily fluids. The most common ways of transmission include unprotected sex, sharing needles, mother-to-child transmission during childbirth, and, more rarely, through transfusions of contaminated blood.

Specific tests and their purposes

Hepatitis B virus-related tests are used for diagnosing and monitoring the infection. Because the infection progresses through various stages and elicits different immune responses, several tests are designed to target specific aspects of the virus and the body’s reaction to it.

• HBc IgM At: These antibodies target the hepatitis B core antigen and are of the IgM type. A positive result indicates an acute hepatitis B infection or a reactivation of a chronic infection.
• Total HBc At: This test detects both IgM and IgG antibodies against the core antigen. A positive result can suggest a current, past, or chronic HBV infection.
• HBe Ag (Hepatitis B e-antigen): The presence of this antigen signifies high viral replication and indicates that the person is potentially infectious. It is typically a marker of active infection.
• HBs Ag (Hepatitis B surface antigen): This is the earliest marker of acute infection, detectable even before symptoms arise. If it remains in the bloodstream for more than six months, it signifies a chronic infection.
• HBs At (Hepatitis B surface antibodies): These antibodies develop following exposure to the virus, either through infection or vaccination, and indicate immunity to HBV.

Each test provides insights into the infection’s phase, the individual’s infectiousness, and their immune response. Evaluating all test results is important to form a comprehensive understanding of the patient’s infection status.